Quarterly report pursuant to Section 13 or 15(d)

Asset Acquisitions - Narrative (Details)

v3.23.3
Asset Acquisitions - Narrative (Details)
 3 Months Ended 9 Months Ended
Aug. 18, 2023
USD ($)
$ / shares
shares
Feb. 09, 2023
Nov. 10, 2022
USD ($)
installment
Sep. 30, 2023
USD ($)
Mar. 31, 2023
shares
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Business Acquisition [Line Items]                
Common stock issued in acquisition of IPR&D asset       $ 21,609,586        
Wind-down costs       $ (14,677)   $ 0 $ 455,504 $ 0
Asset Acquisition, Share Price | $ / shares 3.98              
Discontinued Operations, Disposed of by Sale | Verdelite SPA                
Business Acquisition [Line Items]                
Aggregate purchase price     $ 9,451,233          
Non-refundable deposit     557,705          
Amount paid     5,532,266          
Loss on sale             307,086  
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Disposal Group, Tranche One                
Business Acquisition [Line Items]                
Amount paid     $ 370,350          
Number of installments | installment     5          
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Disposal Group, Tranche Two                
Business Acquisition [Line Items]                
Amount paid     $ 2,777,625          
Number of installments | installment     3          
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term One                
Business Acquisition [Line Items]                
Installment term   18 months            
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term Two                
Business Acquisition [Line Items]                
Installment term   30 months            
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term Three                
Business Acquisition [Line Items]                
Installment term   42 months            
Bird Rock Bio Sub, Inc. (BRB)                
Business Acquisition [Line Items]                
Common stock issued in acquisition of IPR&D asset (in shares) | shares 3,872,184              
Common stock issued in acquisition of IPR&D asset $ 20,000,000              
Stock Issued During Period, Shares, Acquisitions, Period Increase (Decrease) | shares 1,564,194              
Underlying common stock price (in dollars per share) | $ / shares $ 5.16              
Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares 5,436,378       5,436,378      
Asset Acquisition, Percentage of Voting Interests Acquired 100.00%              
Emerald Health Therapeutics, Inc.                
Business Acquisition [Line Items]                
Wind-down costs             $ 38,054